|Targeting Amount (mAb)||
|Turnaround Time||Starting from 5 BDs|
|Additional Services||ELISA, Cell based assay, FACS screening, Octet® BLI assay, Biacore™ SPR assay, etc.|
1.Typically, a minimum sample size of 8 is required.
2.The 5% of the samples will be randomly selected for LC-MS and endotoxin test.
3.Please download the Quotation Form and submit your request.
This popular TurboCHO™ high throughput service is designed to help researchers
scale quickly from promising leads to purified recombinant antibodies in a microscale format, accelerating
their preliminary drug screening process. Applications that would
benefit from this service include epitope binning, ligand competition binding studies, affinity
primary and secondary screen assays, HTP biophysical characterization to assess developability, and more！
Promising leads from your HT studies can be seamlessly integrated into the GenScript workflow to scale-up transient or stable-cell pool/cell line, recombinant antibody production, for milligram to gram-level expression, which can support all your in vitro and in vivo applications！
The newly developed platform is fully automated with QR codes to track all materials and manipulations to eliminate human error and cross-contamination. In addition to its featured Ph.D.-level technical support, we have made remarkable progress in QC analytical approaches, purification solutions, and documentation. Together, these improvements ensure that your antibody samples may be used in downstream applications (i.e., ELISA, Octet® BLI assay, Biacore™ SPR assay, FACS screening, cell-based assay, etc.) performed at GenScript or in-house.
Antibody sequences could be obtained from hybridoma sequencing, phage display libraries, single B cell (B cells) next-generation sequencing (NGS), and more.
From gene synthesis to protein delivery as fast as 8 BDsLearn More
Yield up to gram, from 3 weeksLearn More
Yield up to kg, from 6-7 weeksLearn More
High expression level with ECACC-licensed CHO-K1 cellLearn More
One-stop solution for antibody drug developmentLearn More